Targeting the MDR1 mRNA for degradation with small interfering RNA/antisense oligonucleotide (siRNA/ASO) is also being investigated as a method to ensure target specificity, and combining this with nanoliposomes that target cancer cells has been attempted in an effort to limit toxicity [47,54]. Here, ABCB1 is linked to cancer.